IM Cannabis

Company Overview

Snapshot

Founded in January 2008, IM Cannabis operates with 11–50 employees. The company has raised a total of $68 million across 14 funding rounds from 2 investors. In March 2021, IM Cannabis was listed on NASDAQ.

Business overview

IM Cannabis is an international medical cannabis company specializing in providing premium cannabis products to patients in Israel and Germany, two significant medical cannabis markets. The company utilizes a data-driven approach and a globally sourced product supply chain to support its transnational ecosystem. It operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Medical Cannabis.

Strategic signal

In March 2026, IM Cannabis announced a strategic entry into the cyber drone interception and satellite intelligence markets by signing a non-binding agreement to acquire a 51% stake in Blackaxe Technologies. This move signals a significant strategic pivot for the company, diversifying its operations beyond medical cannabis into high-tech defense and intelligence sectors, potentially opening new revenue streams and investor interest in a different market segment.

Company Intelligence Q&A

What was the most recent financing activity for IM Cannabis?

In June 2026, IM Cannabis raised US$225,000 of gross proceeds in convertible note financing.

When did IM Cannabis report its Q1 2026 financial results?

IM Cannabis Corp. announced its first quarter 2026 financial results on May 13, 2026.

What strategic acquisition did IM Cannabis announce in March 2026?

In March 2026, IM Cannabis announced a strategic entry into the cyber drone interception and satellite intelligence markets by signing a non-binding agreement to acquire a 51% stake in Blackaxe Technologies.

What was a key financial highlight from IM Cannabis's 2025 results?

In March 2026, IM Cannabis reported 2025 results with revenue of C$54.7 million, over 134% growth in Germany, and positive operating cash flow.

When did IM Cannabis list on NASDAQ?

IM Cannabis's common shares began trading on NASDAQ in March 2021.